Health Policy and Technology is a cross-disciplinary journal which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. As a peer-reviewed journal, it aims to foster closer links with policy-makers, health professionals, health technology providers, patient groups and academia.
Ken Redekop leads the journal as its Editor-in-Chief. He is an Associate Professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature.
His current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice.
Health Policy and Technology (HPT), is an official journal of the Fellowship of Postgraduate Medicine (FPM). The FPM was established in 1918 with the aim of educating medical professionals.
HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.
Topics covered by HPT include:
– Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems
– Cross-national comparisons on health policy using evidence-based approaches
– National studies on health policy to determine the outcomes of technology-driven initiatives
– Cross-border eHealth including health tourism
– The digital divide in mobility, access and affordability of healthcare
– Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies
– Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies
– Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making
– Stakeholder engagement with health technologies (clinical and patient/citizen buy-in)
– Regulation and health economics